Evaluation of immunogenicity and safety of VARIVAX™ New Seed Process (NSP) in children
Prior to availability of an effective vaccine, an estimated 4 million cases of varicella occurred annually in the United States, resulting in 10,000 hospitalizations and over 100 deaths. With the increased usage of a two-dose varicella vaccine (as recommended by the ACIP), approval of other VZV-cont...
Saved in:
Main Authors: | Shelly D. Senders (Author), Nickoya D. Bundick (Author), Jianing Li (Author), Carol Zecca (Author), Frans A. Helmond (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults
by: Erin M. Paradis, et al.
Published: (2021) -
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents
by: Erin M. Paradis, et al.
Published: (2021) -
A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)
by: Peter E. Silas, et al.
Published: (2020) -
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
by: Raitis Bobrovs, et al.
Published: (2021) -
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
by: Muhammad Usman Mirza, et al.
Published: (2020)